Conéctese Regístrate


03/09/2014

Tendencias 21

25 Aniversario




CIENCIA ON LINE

ODYSSEY LONG TERM - Long term results underscore efficacy and safety of alirocumab for lowering cholesterol - 31/08/2014 / Leido 318 veces/ Comentarios 0

BARCELONA, Spain – Sunday 31 August: Long term results for the investigational monoclonal antibody alirocumab, show that in addition to significantly reducing cholesterol on top of regular statin therapy, it also reduced the incidence of cardiovascular events, researchers reported in a Hot Line...

ODYSSEY FHI & II - Investigational alirocumab shows lipid-lowering promise - 31/08/2014 / Leido 279 veces/ Comentarios 0

BARCELONA, Spain – Sunday 31 August: An investigational lipid-lowering agent called alirocumab produced superior results compared to placebo in Hot Line studies reported today at ESC Congress 2014. Fuente : http://www.alphagalileo.org/ViewItem.aspx?ItemId=1...

ODYSSEY COMBO II - Investigational agent outshines ezetimibe for lowering cholesterol - 31/08/2014 / Leido 229 veces/ Comentarios 0

BARCELONA, Spain – Sunday 31 August: The investigational drug alirocumab significantly improved cholesterol levels compared to ezetimibe, when added to regular statin therapy in patients with high cholesterol and elevated risk of cardiovascular disease (CVD), according to the ODYSSEY COMBO II...

Solid-TIMI 52 - Darapladib disappoints again – Anti-inflammatory treatment fails to prevent cardiac events - 31/08/2014 / Leido 220 veces/ Comentarios 0

BARCELONA, Spain – Sunday 31 August: A new phase III study evaluating the investigational agent darapladib in patients with an acute coronary syndrome (heart attack or unstable angina) has failed to show a reduction in major coronary events compared to placebo. Results of the double-blind,...

CONFIRM HF – Iron deficient heart failure patients see improvement with intravenous supplementation - 30/08/2014 / Leido 432 veces/ Comentarios 0

BARCELONA, Spain – Saturday 30 August: Heart failure patients with iron deficiency can experience significant and sustainable improvements in functional capacity and quality of life as well as reduced risk of hospital admission for worsening heart failure by receiving just one to two intravenous...

PARADIGM HF – Investigational LCZ696: a new horizon in heart failure - 30/08/2014 / Leido 408 veces/ Comentarios 0

BARCELONA, Spain – Saturday 30 August: An investigational new heart failure drug could be poised to change the face of cardiology based on Hot Line results presented today at ESC Congress 2014. Fuente : http://www.alphagalileo.org/ViewItem.aspx?ItemId=1...

MORE CRT - Quadripolar lead trumps bipolar option in cardiac resynchronisation - 30/08/2014 / Leido 347 veces/ Comentarios 0

BARCELONA, Spain – Saturday 30 August: Use of a quadripolar left ventricular (LV) lead instead of a bipolar option during cardiac resynchronisation therapy (CRT) can decrease complications at six months according to preliminary Hot Line results presented today at ESC Congress 2014. Fuente :...

NECTAR-HF fails to demonstrate clinical benefit of vagus nerve stimulation in Heart Failure - 30/08/2014 / Leido 359 veces/ Comentarios 0

BARCELONA, Spain – Saturday 30 August: Stimulating the vagus nerve, which regulates the body’s internal organ systems including the heart, does not improve cardiac function in heart failure patients, according to results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) trial. Fuente :...

POPE 2 – Another anti-Inflammatory fails to reduce post-surgical fluid around the heart - 30/08/2014 / Leido 281 veces/ Comentarios 0

BARCELONA, Spain – Saturday 30 August: The anti-inflammatory drug colchicine is not an effective treatment for cardiac patients who develop a condition called post-operative pericardial effusion (POPE) – a build-up of fluid around the heart, according to a new study. The POPE-2 study, presented as...

Factor in naked mole rat's cells enhances protein integrity - 29/08/2014 / Leido 162 veces/ Comentarios 0

A factor in naked mole rat cells could be one of the secrets to how the rodent defies aging, researchers say. Naked mole rats, which burrow through underground tunnels in their native East Africa, are nearly hairless rodents. They live as long as 32 years. Naked mole rats maintain cancer-free good...
1 ... « 2 3 4 5 6 7 8 » ... 2058

Forma parte de esta comunidad y contribuye al desarrollo e independencia de los contenidos de Tendencias21